For an otherwise healthy adult with a cold sore, can I prescribe oral acyclovir 400 mg three times daily for five days?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, you can prescribe acyclovir 400 mg three times daily for five days for an otherwise healthy adult with a cold sore (herpes labialis).

This regimen is explicitly supported by CDC guidelines as one of three recommended dosing options for treating recurrent herpes simplex virus infections, including herpes labialis. 1

Evidence-Based Recommendation

The 1993 CDC Sexually Transmitted Diseases Treatment Guidelines specifically list three equivalent regimens for recurrent HSV episodes 1:

  • Acyclovir 200 mg orally 5 times daily for 5 days, OR
  • Acyclovir 400 mg orally 3 times daily for 5 days, OR
  • Acyclovir 800 mg orally 2 times daily for 5 days

Your proposed regimen matches the second option exactly.

Clinical Context and Timing

Treatment should be initiated at the earliest sign or symptom (prodrome) of recurrence to achieve maximum benefit 1. The guidelines note that when treatment begins during the prodrome or within 2 days of lesion onset, patients experience limited but meaningful benefit. Starting treatment after this window significantly reduces efficacy.

Supporting Evidence

The FDA-approved labeling for oral acyclovir confirms this dosing for intermittent therapy of recurrent genital herpes, stating "200 mg every 4 hours, 5 times daily for 5 days" with therapy initiated at the earliest sign or symptom 2. While the FDA label specifically addresses genital herpes, the CDC guidelines extend these regimens to all mucocutaneous HSV infections including herpes labialis 1.

Research evidence supports oral acyclovir's efficacy for herpes labialis. A 2007 systematic review found that systemic acyclovir 400 mg 3 times daily for 3-5 days effectively treats recurrent herpes labialis in immunocompetent patients 3. The treatment reduces lesion duration by approximately 1 day compared to placebo.

Important Caveats

  • The patient must be immunocompetent. Immunocompromised patients may require higher doses (400 mg 5 times daily) or longer treatment duration 1

  • Renal function matters. For patients with creatinine clearance <10 mL/min, reduce the dose to 200 mg every 12 hours 4, 2

  • Food doesn't affect absorption, so the medication can be taken with or without meals 2

  • This treats but doesn't cure. Acyclovir does not eradicate latent virus or prevent future recurrences once discontinued 1

Alternative Considerations

While your proposed regimen is appropriate, the 800 mg twice daily option offers equivalent efficacy with better adherence due to less frequent dosing 1. However, the 400 mg three times daily regimen remains a valid, guideline-supported choice that balances efficacy, convenience, and cost.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.